Thalys Medical Technology Group Corporation (SHA:603716)
China · Delayed Price · Currency is CNY 22.49
+0.11 (0.49%)
Feb 4, 2026, 3:00 PM CST
SHA:603716 Market Cap
SHA:603716 has a market cap or net worth of 4.62 billion as of February 4, 2026. Its market cap has increased by 258.71% in one year.
Market Cap
4.62B
Enterprise Value
5.02B
Revenue
1.25B
Ranking
n/a
PE Ratio
n/a
Stock Price
22.49
Market Cap Chart
Since October 31, 2016, SHA:603716's market cap has increased from 1.97B to 4.62B, an increase of 133.81%. That is a compound annual growth rate of 9.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 4.62B | 8.91% |
| Dec 31, 2025 | 4.24B | 213.84% |
| Dec 31, 2024 | 1.35B | -36.50% |
| Dec 29, 2023 | 2.13B | 0.51% |
| Dec 30, 2022 | 2.12B | -24.46% |
| Dec 31, 2021 | 2.80B | -14.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Runda Medical Technology | 9.65B |
| Amoy Diagnostics | 8.46B |
| Beijing Strong Biotechnologies,Inc. | 7.74B |
| Maccura Biotechnology Co.Ltd | 7.34B |
| Cowealth Medical China | 7.08B |
| SMO ClinPlus CO.,LTD. | 5.51B |
| Guangdong Hybribio Biotech | 4.80B |
| Shanghai Labway Clinical Laboratory | 4.48B |